CDEK by Data4ThePeople
Sign in Sign up
← All organizations

POINT Biopharma

For profitWebsite ↗

Also known as: POINT Biopharma

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Feb 25, 2021

Last known activity

Sep 2, 2022

Acquired by Eli Lilly on Oct 3, 2023

Timeline

2020s

  1. Feb 25, 2020

    POINT Biopharma— Founded

  2. Oct 3, 2023

    Eli Lilly— Acquired By

Drugs by trial phase (7 distinct, 5 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Recent trials (7)

Details

Founded
Toronto, CA Feb 25, 2020
Last known activity
Sep 2, 2022